These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 17420319

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.
    Hart PE, Lodi R, Rajagopalan B, Bradley JL, Crilley JG, Turner C, Blamire AM, Manners D, Styles P, Schapira AH, Cooper JM.
    Arch Neurol; 2005 Apr; 62(4):621-6. PubMed ID: 15824263
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A 22-Year Follow-up Study of Long-term Cardiac Outcome and Predictors of Survival in Friedreich Ataxia.
    Pousset F, Legrand L, Monin ML, Ewenczyk C, Charles P, Komajda M, Brice A, Pandolfo M, Isnard R, Tezenas du Montcel S, Durr A.
    JAMA Neurol; 2015 Nov; 72(11):1334-41. PubMed ID: 26414159
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
    Di Prospero NA, Baker A, Jeffries N, Fischbeck KH.
    Lancet Neurol; 2007 Oct; 6(10):878-86. PubMed ID: 17826341
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cerebrospinal fluid concentrations of idebenone in Friedreich ataxia patients.
    Artuch R, Aracil A, Mas A, Monrós E, Vilaseca MA, Pineda M.
    Neuropediatrics; 2004 Apr; 35(2):95-8. PubMed ID: 15127307
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia.
    Seznec H, Simon D, Monassier L, Criqui-Filipe P, Gansmuller A, Rustin P, Koenig M, Puccio H.
    Hum Mol Genet; 2004 May 15; 13(10):1017-24. PubMed ID: 15028670
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Progression of ataxia in patients with Machado-Joseph disease.
    França MC, D'Abreu A, Nucci A, Cendes F, Lopes-Cendes I.
    Mov Disord; 2009 Jul 15; 24(9):1387-90. PubMed ID: 19441132
    [Abstract] [Full Text] [Related]

  • 15. International Cooperative Ataxia Rating Scale (ICARS): appropriate for studies of Friedreich's ataxia?
    Cano SJ, Hobart JC, Hart PE, Korlipara LV, Schapira AH, Cooper JM.
    Mov Disord; 2005 Dec 15; 20(12):1585-91. PubMed ID: 16114019
    [Abstract] [Full Text] [Related]

  • 16. Friedreich's ataxia: idebenone treatment in early stage patients.
    Artuch R, Aracil A, Mas A, Colomé C, Rissech M, Monrós E, Pineda M.
    Neuropediatrics; 2002 Aug 15; 33(4):190-3. PubMed ID: 12368988
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia.
    Lynch DR, Perlman SL, Meier T.
    Arch Neurol; 2010 Aug 15; 67(8):941-7. PubMed ID: 20697044
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.